Jain Global’s CRISPR Therapeutics CRSP Stock Holding History

Jain Global’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,155	Closed	-$242K	–	1124
2024 Q4	$242K	Buy	+6,155	New	+$291K	0.01%	601

Other funds holding CRSP

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jain Global's CRSP Position: Q1 2025 in Review

Jain Global sold out of CRISPR Therapeutics (CRSP) in Q1 2025, closing a stake of 6,155 shares — an estimated $242K sold.

Jain Global first reported a position in CRSP in Q4 2024 and held it in 1 quarter. The position peaked at $242K in Q4 2024. 396 funds tracked by Wall St. Rank hold CRSP as of Q1 2025.

Jain Global reported no remaining CRISPR Therapeutics position as of Q1 2025 after selling out during the quarter.
Jain Global sold 6,155 CRISPR Therapeutics shares in Q1 2025, an estimated $242K.
Jain Global first reported a position in CRISPR Therapeutics in Q4 2024 and held it in 1 quarter.
Jain Global's CRISPR Therapeutics position peaked at $242K in Q4 2024.
396 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2025.

Based on Jain Global's 13F filing for Q1 2025, filed 15 May 2025.